Characterization of the Analgesic Effect of CBD in Healthy, Normal Volunteers

Completed · Phase 1/Phase 2 · Has a placebo group

Conditions studied: Pain

In brief

The purpose of this double-blind, placebo-controlled study is to determine the analgesic effects of cannabidiol (CBD), a chemical constituent found in cannabis that does not have intoxicating effects. The analgesic effects of CBD will be assessed using the Cold-Pressor Test (CPT), a laboratory model of pain which has predictive validity for the clinical use of analgesics.

Key facts

Study ID

NCT02751359

Run by

University of California, Los Angeles

People needed

18

Starts

2016-07-01

Expected to finish

2020-04-01

Last updated by the study team

2021-05-12

Who can join

Age: 21 and older, up to 50. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Able to perform study procedures
• Women practicing an effective form of birth control

You may not qualify if…

• Female subjects who are currently pregnant or breastfeeding.
• Current illicit drug use
• Presence of significant medical illness
• History of heart disease
• Request for drug treatment
• Current parole or probation
• Recent history of significant violent behavior
• Major psychiatric disorder
• Current use of any prescription or over-the-counter medication
• Current pain
• Clinically significant Raynaud's syndrome

Where it is running

• Cooper — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.